Location and Density of α- and β-Adrenoreceptor Sub-types in Myocardium After Mechanical Left Ventricular Unloading

Journal of Heart and Lung Transplantation

Volumn 27, Issue 7, 2008, Pages 710-717

  Schnee, Pippa M ^a,b   Shah, Naeema ^a   Bergheim, Marianne ^a   Poindexter, Brian J ^b   Buja, L Maximilian ^a,b   Gemmato, Courtney ^a   Radovancevic, Branislav ^a   Letsou, George V ^b   Frazier, O Howard ^a   Bick, Roger J ^b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR EQUIPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; HEART FAILURE; HEART MUSCLE; HUMAN; HUMAN TISSUE; IMPLANTATION; MALE; MUSCLE HYPERTROPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION;

ADULT; BIOPSY, NEEDLE; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA;

EID: 45649085449     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.03.015     Document Type: Article

References (46)

1. Brodde O.E., Michel M.C., Wang X.L., and Zerkowski H.R. Chronic beta-adrenoceptor antagonist treatment modulates human cardiac and vascular beta-adrenoceptor density in a subtype-selective fashion. J Hypertens 6 suppl (1988) S497-S500
2. Summers R.J., Molnaar P., Russell F., et al. Coexistence and localization of beta 1- and beta 2-adrenoceptors in the human heart. Eur Heart J 10 suppl B (1989) 11-21
3. Bohm M., Flesch M., and Schnabel P. Beta-adrenergic signal transduction in the failing and hypertrophied myocardium. J Mol Med 75 (1997) 842-848
4. Brodde O.E., Zerkowski H.R., Doetsch N., et al. Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol 14 (1989) 323-331
5. Chavey II W.E. The importance of beta blockers in the treatment of heart failure. Am Fam Phys 62 (2000) 2453-2462
6. Dobre D., van Jaarsveld C.H., deJongste M.J., Haaijer Ruskamp F.M., and Ranchor A.V. The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 16 (2007) 152-159
7. Goldstein S. Beta blocker therapy in African American patients with heart failure. Heart Fail Rev 9 (2004) 161-167
8. Young R., and Worthley L.I. Current concepts in the management of heart failure. Crit Care Resusc 6 (2004) 31-53
9. Frigerio M., and Roubina E. Drugs for left ventricular remodeling in heart failure. Am J Cardiol 96 (2005) 10L-8
10. Radovancevic B., Vrtovec B., and Frazier O.H. Left ventricular assist devices: an alternative to medical therapy for end-stage heart failure. Curr Opin Cardiol 18 (2003) 210-214
11. Bick R.J., Grigore A.M., Poindexter B.J., et al. Left ventricular unloading with an assist device results in receptor relocalization as well as increased beta-adrenergic receptor numbers: are these changes indications for outcome?. J Card Surg 20 (2005) 332-336
12. Grigore A., Poindexter B., Vaughn W.K., et al. Alterations in alpha adrenoreceptor density and localization after mechanical left ventricular unloading with the Jarvik flowmaker left ventricular assist device. J Heart Lung Transplant 24 (2005) 609-613
13. Ferrari M., Kadipasaoglu K.A., Croitoru M., et al. Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant 24 (2005) 226-228
14. Hon J.K., and Yacoub M.H. Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg 75 suppl (2003) S36-S41
15. Siegenthaler M.P., Frazier O.H., Beyersdorf F., et al. Mechanical reliability of the Jarvik 2000 Heart. Ann Thorac Surg 81 (2006) 1752-1758
16. Birks E.J., Yacoub M.H., Banner N.R., and Khaghani A. The role of bridge to transplantation: should LVAD patients be transplanted?. Curr Opin Cardiol 19 (2004) 148-153
17. Dandel M., Weng Y., Siniawski H., Potapov E., Lehmkuhl H.B., and Hetzer R. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 112 (2005) I-37-I-45
18. Frazier O.H., Myers T.J., Westaby S., and Gregoric I.D. Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg 237 (2003) 631-636
19. Ogletree-Hughes M.L., Stull L.B., Sweet W.E., et al. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 104 (2001) 881-886
20. DiPaola N.R., Sweet W.E., Stull L.B., Francis G.S., and Schomisch Moravec C. Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied and failing human hearts: transition from hypertrophy to failure. J Mol Cell Cardiol 33 (2001) 1283-1295
21. Shan K., Bick R.J., Poindexter B.J., et al. Altered adrenergic receptor density in myocardial hibernation in humans: a possible mechanism of depressed myocardial function. Circulation 102 (2000) 2599-2606
22. Feldman A.M. From clinical trials to clinical practice: what we know and do not know about beta-blockers and the heart. J Card Fail 6 (2000) 34-39
23. Huang Y., Wright C.D., Merkwan C.L., et al. An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes. Circulation 115 (2007) 763-772
24. Baker J.G., Hall I.P., and Hill S.J. Agonist actions of "beta-blockers" provide evidence for two agonist activation sites or conformations of the human beta1-adrenoceptor. Mol Pharmacol 63 (2003) 1312-1321
25. Bundkirchen A., Brixius K., Bolck B., Nguyen Q., and Schwinger R.H. Beta 1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies. Eur J Pharmacol 460 (2003) 19-26
26. Bavendiek U., Brixius K., Frank K., et al. Altered inotropism in the failing human myocardium. Basic Res Cardiol 91 suppl 2 (1996) 9-16
27. Kohi M., Yang H.T., and Endoh M. Myocardial alpha 1A-adrenoceptor subtypes in rabbit: differentiation by a selective antagonist, HV723. Eur J Pharmacol 250 (1993) 95-101
28. Kurokawa H., Murray P.A., and Damron D.S. Propofol attenuates beta-adrenoreceptor-mediated signal transduction via a protein kinase C-dependent pathway in cardiomyocytes. Anesthesiology 96 (2002) 688-698
29. Gregorini L. Adrenergic receptors: the key therapeutic target. J Clin Basic Cardiol 7 (2004) 30-32
30. 2+ cycling to augment contraction in mouse heart. J Physiol 521 (1999) 351-361
31. Tseng Y.T., Kopel R., Stabila J.P., et al. Beta-adrenergic receptors (betaAR) regulate cardiomyocyte proliferation during early postnatal life. FASEB J 15 (2001) 1921-1926
32. Varma D.R., and Deng X.F. Cardiovascular alpha1-adrenoceptor subtypes: functions and signaling. Can J Physiol Pharmacol 78 (2000) 267-292
33. Knowlton K.U., Michel M.C., Itani M., et al. The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem 268 (1993) 15374-15380
34. Yun J., Zuscik M.J., Gonzalez-Cabrera P., et al. Gene expression profiling of alpha(1b)-adrenergic receptor-induced cardiac hypertrophy by oligonucleotide arrays. Cardiovasc Res 57 (2003) 443-455
35. Hopkins S.R., Bogaard H.J., Niizeki K., Yamaya Y., Ziegler M.G., and Wagner P.D. Beta-adrenergic or parasympathetic inhibition, heart rate and cardiac output during normoxic and acute hypoxic exercise in humans. J Physiol 550 (2003) 605-616
36. Poindexter B.J., Smith J.R., Buja L.M., and Bick R.J. Calcium signaling mechanisms in dedifferentiated cardiac myocytes: comparison with neonatal and adult cardiomyocytes. Cell Calcium 30 (2001) 373-382
37. Koshimizu T.A., Tanoue A., Hirasawa A., Yamauchi J., and Tsujimoto G. Recent advances in alpha1-adrenoceptor pharmacology. Pharmacol Ther 98 (2003) 235-244
38. Rorabaugh B.R., Gaivin R.J., Papay R.S., et al. Both alpha(1A)- and alpha(1B)-adrenergic receptors crosstalk to down regulate beta(1)-ARs in mouse heart: coupling to differential PTX-sensitive pathways. J Mol Cell Cardiol 39 (2005) 777-784
39. Badino P., Odore R., and Re G. Are so many adrenergic receptor subtypes really present in domestic animal tissues?. A pharmacological perspective. Vet J 170 (2005) 163-174
40. Rashidi A., Rahman M., and Wright Jr. J.T. Which drug should be used to treat patients with uncomplicated essential hypertension?. Curr Opin Nephrol Hypertens 15 (2006) 303-308
41. Schnee P.M., Shah N., Bergheim M., et al. Reversal of myocyte hypertrophy by ventricular unloading: cardiac improvement without adrenergic receptor up-regulation and relocalization. Med Gen Med 8 (2006) 45
42. Wei J.W., and Sulakhe P.V. Identity of [3H]dihydroalprenolol binding sites and beta-2 adrenergic receptors coupled with adenylate cyclase in guinea-pig skeletal muscle sarcolemma: general properties and structure-activity relationships. J Pharmacol Exp Ther 214 (1980) 186-196
43. Brixius K., Bloch W., Ziskoven C., et al. Beta3-adrenergic eNOS stimulation in left ventricular murine myocardium. Can J Physiol Pharmacol 84 (2006) 1051-1060
44. Bick R.J., Poindexter B.J., Buja L.M., et al. Improved sarcoplasmic reticulum function after mechanical left ventricular unloading. Cardiovasc Pathobiol 2 (1997) 159-166
45. Bruckner B.A., Stetson S.J., Perez-Verdia A., et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 20 (2001) 457-464
46. Xydas S., Rosen R.S., Ng C., et al. Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. J Heart Lung Transplant 25 (2006) 7-15